Turning drug discovery into speed dating

Published:24.05.22 — EPFL spin-off ArcoScreen has developed a platform that turns the discovery of new drugs for Alzheimer’s and Parkinson’s disease, diabetes and cancer from a marathon into a sprint. The firm’s microfluidic readout system assesses the response of G-protein-coupled receptors (GPCRs) to new substances, delivering significant time and financial gains for pharmaceutical companies.

Objects can now be 3D-printed in opaque resin

Published:23.05.22 — A team of EPFL engineers has developed a 3D-printing method that uses light to make objects out of opaque resin in a matter of seconds. Their breakthrough could have promising applications in the biomedical industry, such as to make artificial arteries.

The missing piece to faster, cheaper and more accurate 3D mapping

Published:20.05.22 — Engineers at EPFL and the University of Geneva believe they hold the key to automated drone mapping. By combining artificial intelligence with a new algorithm, their method promises to considerably reduce the time and resources needed to accurately scan complex landscapes.

Appointment of EPFL professors

Published:20.05.22 — The Board of the Swiss Federal Institutes of Technology has announced the appointment of professors at EPFL.

New Swiss Alliance for Capacity-building in PeaceTech

Published:19.05.22 — EPFL and The Geneva Graduate Institute (formerly IHEID) have signed an agreement to create the Swiss PeaceTech Alliance, which will bring together complementary knowledge needed to build capacity internationally in the field of PeaceTech. The partners are very proud to further announce that the Geneva Peacebuilding Platform (GPP) has also decided to join the alliance.